Omecamtiv Mecarbil not checked

Cytokinetics · AMG 423 · CK-1827452

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
12 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Main trialPhase 3
“The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in patients with heart failure and severely reduced ejection fraction.”In the company’s words, NCT06736574 on ClinicalTrials.gov
Other names
AMG 423 · CK-1827452

Other drugs for Heart Failure

All 42 drugs for Heart Failure

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials12

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Sep 2027 Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Phase 3Completed 14 Sep 2020 Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction
Phase 3Completed 8 Nov 2021 Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure
Phase 3Withdrawn 27 Nov 2026 Omecamtiv Mecarbil Post-trial Access Study
Phase 2Completed Feb 2009 A Study of CK-1827452 Infusion in Stable Heart Failure
Phase 2Withdrawn May 2011 Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients
Phase 2Completed Apr 2013 Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
Phase 2Completed 22 Jul 2015 COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
Phase 2Completed 6 Apr 2017 Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction
Phase 1Completed Jan 2013 Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency
Phase 1Completed 6 Jan 2016 Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults
Phase 1Completed 4 Mar 2020 Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Omecamtiv Mecarbil

Following is part of Solo: you see every change to Omecamtiv Mecarbil the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in